Neuropeptides and asthma

Current Opinion in Pulmonary Medicine

Volumn 4, Issue 1, 1998, Pages 16-24

  Choi, Dong Chull ^a   Kwon, O Jung ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; NEUROPEPTIDE;

ANIMAL; ASTHMA; BRONCHUS; HUMAN; IMMUNOLOGY; INNERVATION; LUNG; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; ASTHMA; BRONCHI; HUMANS; INFLAMMATION MEDIATORS; LUNG; NEUROPEPTIDES;

EID: 0031607163     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-199801000-00004     Document Type: Article

References (104)

1. National Institutes of Health: Global Initiative for Asthma. 1995. [National Institutes of Health publication no. 95-3659.]
2. Shelhamer JH, Levine SJ, Wu T, Jacoby DB, Kaliner MA, Rennard SI: Airway inflammation. Ann Intern Med 1995, 123:288-304.
3. Uddman R, Sundler F, Cardell LO, Luts A: Neuropeptides in the lung. In The Lung, edn 2. Edited by Crystal RG, West JB, Barnes PJ, Weibel ER. Philadelphia: Lippincott-Raven; 1997:103-115. A review of the role of neuropeptides and the distribution of nerve fibers containing neuropeptides.
4. Barnes PJ: Neuropeptides and asthma. Am Rev Respir Dis 1991, 143:S28-S32.
5. Casale TB: Neurogenic control of inflammation and airway function. In Allergy, edn 4. Edited by Middletone E, Reed CE, Ellis EF, Adkinson F, Yungunger JW, Busse WW. St.Louis: Mosby; 1993:650-671.
6. Uddman R, Sundler F: Neuropeptides in the airways: a review. Am Rev Respir Dis 1987, 136:S3-S8.
7. Barnes PJ: Other regulatory peptides. In Asthma, edn 1. Edited by Barnes PJ, Grunstein MM, Leff AR, Woolcock AJ. Philadelphia: Lippincott-Raven; 1997: 1065-1076. An excellent review of the effects of sensory neuropeptides relevant to the pathophysiology of asthma.
8. Richardson JB: Nerve supply to the lungs. Am Rev Respir Dis 1979, 119:785-802.
9. MacKay TW, Fitzpatrick MF, Douglas NJ: Nonadrenergic, noncholinergic nervous system and overnight airway caliber in asthmatic and normal subjects. Lancet 1991, 338:1289-1292.
10. Michoud MC, Amyot R, Jenneret-Grosjean A, Coutoure J: Reflex decrease of histamine induced bronchoconstriction after laryngeal stimulation in humans. Am Rev Respir Dis 1987, 137:618-622.
11. Ichinose M, Inoue H, Miura M, Takishima T: Nonadrenergic bronchodilation in normal subjects. Am Rev Respir Dis 1988, 138:31-34.
12. Verleben GM: Neural mechanisms and axon reflexes in asthma. Biochem Pharmacol 1996, 51:1247-1257. An excellent review of the role of axon reflex in the pathophysiology of asthma.
13. Robberecht P, Waelbroeck M, deNeef P, Camus JC, Coy DH, Christophe J: Pharmacological characterization of VIP receptors in human lung membranes. Peptides 1988, 9:339-345.
14. Carstairs JR, Barnes PJ: Visuailization of vasoactive intestinal peptide receptors in human and guinea pig lung. J Pharmacol Exp Ther 1986, 239:249-255.
15. Palmer JB, Cuss FMC, Barnes PJ: VIP and PHM and their role in nonadrenergic inhibitory responses in isolated human airways. J Appl Physiol 1986, 61:1322-1328.
16. Lundberg JM, Fahrenkrug J, Hokfelt T, Martling CR, Larsson O, Tatemoto K, Angard A: Co-existence of peptide histidine isoleucine (PHI) and VIP in nerves regulating blood flow and bronchial smooth muscle tone in various mammals including man. Peptides 1984, 5:593-606.
17. Parnes PJ, Brown MJ: Venous plasma histamine in exercise and hyperventilation-induced asthma in man. Clin Sci 1981, 61:159-162.
18. Palmer JBD, Cuss FMC, Warren JB, Barnes PJ: The effect of infused vasoactive intestinal peptide on airway function in normal subjects. Thorax 1986, 41:663-666.
19. Widdicombe JG: The NANC system and airway vasculature. Aren Int Pharmacodyn Trier 1983, 55:1844-1848.
20. Matran R, Alving K, Martling CR, Lacroix JM: Effects of neuropeptides and capsaicin on tracheobronchial blood flow in the pig. Acta Physiol Scand 1989, 135:335-342.
21. Barnes PJ, Dixon CMS: The effect of inhaled vasoactive intestinal peptide on bronchial hyperreactivity in man. Am Rev Respir Dis 1984, 130:162-166.
22. Ollerenshaw S, Jarvis D, Woolcock A, Sullivan C, Scheibner T: Absence of immunoreactive vasoactive intestinal polypeptide in tissue from lungs of patients with asthma. N Engl J Med 1989, 320:1244-1248.
23. Howarth PH, Britten KM, Djukanovic RJ, Wilson JW, Holgate ST, Springall DR, Polak JM: Neuropeptide containing nerves In human airways in vivo: a comparative study of atopic asthma and nonatopic asthma. Thorax 1990, 45:786-787.
24. Lilly CM, Bai TR, Shore SA, Hall AE, Drazen JM: Neuropeptide content of lungs from asthmatic and nonasthamtic patients. Am J Respir Crit Care Med 1995, 151:548-553.
25. Caughey GH, Leidig F, Viro NF, Nadel JA: Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase. J Pharmacol Exp Ther 1988, 244:133-137.
26. Tatemoto K: PHI: a new brain-gut peptide. Peptides 1984, 5:151-154.
27. Lindh B, Lundberg JM, Hokfelt T: NPY-, galanin-, VIP/PHI-, CGRP- and substance P-immunoreactive neuronal populations in cat autonomic and sensory ganglia and their projections. Cell Tissue Res 1989, 256:259-273.
28. Christofides ND, Yiangou Y, Piper PJ, Ghatei MA, Sheppard MN, Tatemoto K, Polak JM, Bloom SR: Distribution of peptide histidine isoleucine in the mammalian respiratory tract and some aspects of its pharmacology. Endocrinology 1984, 115:1958-1963.
29. Laitinen LA, Laitinen A, Salonen RO, Widdicombe JG: Vascular actions of airway neuropeptides. Am Rev Respir Dis 1987, 136:559-564.
30. Webber SE: The effects of neuropeptide histidine isoleucine and neuropeptide Y on mucus volume output from ferret trachea. Br J Pharmacol 1988, 55:40-54.
31. Grundström N, Anderson RGG, Wikberg JES: Pharmacological characterization of the autonomous innervation of guinea pig tracheobronchial smooth muscle. Acta Pharmacol Toxicol 1981, 49:150-157.
32. Ellis JL, Undem BJ: Nonadrenergic, noncholinergic contraction in electrically field stimulated guinea pig trachea. Br J Pharmacol 1990, 101:875-880.
33. Pype JL, Verleden GM, Demedts MG: 5-HT modulates noncholinergic contraction in guinea pig airways in vitro by prejunctional 5-HT, like receptor. J Appl Physiol 1994, 77:1135-1141.
34. Martling CR, Saria A, Anderson P, Lundberg JM: Capsaicin pretreatment Inhibits vagal cholinergic and noncholinergic control of pulmonary mechanics in the guinea pig. Naunyn Schmiedebergs Arch Pharmacol 1984, 325:343-348.
35. Lundberg JM, Saria A, Brodin E, Rossel S, Folkers K: A substance P antagonist inhibits vagally induced increase in vascular permeability and bronchial smooth muscle in the guinea pig. Proc Natl Acad Sci USA 1983, 80:1120-1124.
36. Lou PY, Lee LY, Satoh H, Lundberg JM: Postjunctional inhibitory effect of NK-2 receptor SR 48968, on sensory NANC bronchoconstriction in the guinea pig. Br J Pharmacol 1993, 109:765-773.
37. Foreman JC, Jordan C: Neurogenic inflammation. Trends Pharmacol Sci 1984, 5:116-119.
38. Szolcsányi J: Antidromic vasodilation and neurogenic inflammation. Agents Actions 1988, 23:4-11.
39. Reynolds PN, Holmes MD, Scicchitano R: Role of tachykinins in bronchial hyperresponsiveness. Clin Exp Pharmacol Physiol 1997, 24:273-280. A review of the role of tachykinins in neurogenic inflammation of the airways
40. Lundberg JM, Hokfelt T, Martling CR, Saria A, Cuelo C: Substance-P Immunoreactive sensory nerves in the lower respiratory tract of various mammals including man. Cell Tissue Res 1984, 235:251-261.
41. Stretton CD, Belvisi MG, Barnes PJ: Sensory nerve depletion potentiates inhibitory nonadrenrgic, noncholinergic nerves in guinea pig airways. Eur J Pharmacol 1990, 184:333-337.
42. Stretton CD, Belvisi MG, Barnes PJ: The effect of sensory nerve depletion on cholinergic neurotransmission in guinea pig airways. J Pharmacol Exp Ther 1992, 260:1073-1080.
43. Lundberg JM, Martling CR, Saria A: Substance P and capsaicin-induced contraction of human bronchi. Acta Physiol Scand 1983, 119:49-53.
44. Fuller RW, Dixon CMS, Barnes PJ: The bronchoconstrictor response to inhaled capsaicin in humans. J Appl Physiol 1985, 85:1080-1084.
45. Midgren B, Hansson L, Karlsson JA, Simpsom BG, Persson CGA: Capsaicin-induced cough in humans. Am Rev Respir Dis 1992, 146:347-351.
46. Chung KF: Airway neuropeptides and neutral endopeptidase in asthma [editorial]. Clin Exp Allergy 1996, 26:491-493. A review of the role of neutral endopeptidase in asthma.
47. Barnes PJ, Baraniuk J, Kunkel GHH: Neuropeptides In the respiratory tract Am Rev Respir Dis 1991, 144(part I):1187-1198.
48. Barnes PJ, Baraniuk J, Kunkel GHH: Neuropeptides In the respiratory tract Am Rev Respir Dis 1991, 144(part II):1391-1399.
49. Barnes PJ: Sensory neuropeptides. In Asthma, edn 1. Edited by Barnes PJ, Grunstein MM, Leff AR, Woolcock AJ. Philadelphia: Lippincott-Raven; 1997: 1051-1063. A comprehensive review of the physiologic and pathologic role of regulatory neuropeptides.
50. Martling CR, Theodorsson-Norheim E, Lundberg JM: Occurrence and effects of multiple tachykinins: substance P, neurokinin A, and neuropeptide K in human lower airways. Life Sci 1987, 40:1633-1643.
51. Komatsu T, Yamamoto M, Shimokata K, Nagura H: Distribution of substance P-immunoreactive and calcitonin gene-related peptide-immunoreactive nerves in normal human lungs. Int Arch Allergy Appl Immunol 991, 95:23-28.
52. Carstairs JR, Barnes PJ: Autoradiographic mapping of substance P receptors in lung. Eur J Pharmacol 1986, 127:295-296.
53. Reynolds PN, Schiccitano R, Holmes M: Glucocorticoid modulation of tachykinin receptor expression in human airway epithelium. Am J Respir Crit Care Med 1995, 151:A174.
54. Bai TR, Zhou D, Weir T, Walker B, Hegele R, Hayashi S, McKay K, Bondy GP, Fong T: Substance P (NK1)- and neurokinin A (NK2)-receptor gene expression in inflammatory airway diseases. Am J Physiol 1995, 269:L309-L317.
55. Mussap CJ, Geraghty DP, Burcher E: Tachykinin receptors: a radio-ligand binding perspective. J Neurochem 1993, 60:1987-2009.
56. Naline E, Devallier P, Drapeau G, Totly L, Bakdash H, Regoli D, Advenier C: Characterization of neurokinin effects on receptor selectivity in human isolated bronchi. Am Rev Respir Dis 1989, 140:679-686.
57. Advenier C, Naline E, Titly L: Effects on the isolated human bronchus of SR 48968, a potent and selective nonpeptide antagonist of the neurokinin A (NK2) receptors. Am Rev Respir Dis 1992, 146:1177-1181.
58. Frossard N, Barnes PJ: Effects of tachykinins on small human airways. Neuropeptides 1991, 19:157-162.
59. Evans TW, Dixon CM, Clarke B, Conradson TB, Barnes PJ: Comparison of neurokinin A and substance P on cardiovascular and airway function in man. Br J Pharmacol 1988, 25:273-275.
60. Joos G, Pauwels R, van der Straeten ME: Effect of inhaled substance P and neurokinin A in the airways of normal and asthmatic subjects. Thorax 1987, 42:779-783.
61. Fuller RW, Maxwell DL, Dixons CM, McGregor GP, Barnes VF, Bloom SR, Barnes PJ: The effect of substance P on cardivascular and respiratory function of human subjects. J Appl Physiol 1987, 62:1473-1479.
62. Devallier P, Advenier C, Drapeau G, Marsac J, Regoli D: Comparison of the effects of epithelium removal and of an enkephalinase inhibitor on the neurokinin-induced contractions of guinea pig isolated trachea. Br J Pharmacol 1988, 94:675-684.
63. Frossard N, Rhoden KJ, Barnes PJ: Influence of epithelium on guinea pig airway responses to tachykinins: role of endopeptidase and cyclooxygenase. J Pharmacol Exp Ther 1989, 248:292-298.
64. Ramnarine SJ, Hirayama Y, Barnes PJ, Rogers DF: "Sensory-efferent" neural control of mucus secretiom: characterization using tachykinin receptor antagonists in ferret trachea In vitro. Br J Pharmacol 1994, 113:1183-1190.
65. Kuo H, Barnes PJ, Rogers DF: Capsaicin and sensory neuropeptidergic stimulation of goblet cell secretion in guinea pig airways. J Physiol 1990, 431:629-641.
66. Rogers DF, Aursudkij B, Barnes PJ: Effects of tachykinins on mucus secretion on human bronchi in vitro. Eur J Pharmacol 1989, 174:283-266.
67. Lötvall JO, Lemen RJ, Hui KP, Barnes PJ, Chung KF: Airflow obstruction after substance P aerosol: contribution of airway and pulmonary edema. J Appl Physiol 1990, 69:1473-1478.
68. Fuller RW, Conradson T, Dixon CMS, Crossman DC, Barnes PJ: Sensory neuropeptide effects in human skin. Br J Pharmacol 1987, 92:781-788.
69. Nadel JA: Neutral endopeptidase modulates neurogenic inflammation. Eur Respir J 1991, 4:745-754.
70. Shore SA, Stimler-Gerard NP, Coats SR, Drazen JM: Substance P-induced bronchoconstriction in guinea pig: enhancement by inhibitors of neutral endopeptidase and angiotensin converting enzyme. Am Rev Respir Dis 1988, 137:331-336.
71. Martins MA, Shore SA, Gerard NP, Gerald C, Drazen JM: Peptidase modulation of the pulomnary effects of tachykinins in tracheal super-fused guinea pig lungs. J Clin Invest 1990, 85:170-176.
72. Lötvall JO, Skoogh B, Barnes PJ, Chung KF: Effects of aerosolized substance P on lung resistance in guinea pigs: a comparison between neutral endopeptidase and angiotensin converting enzyme. Br J Pharmacol 1990, 100:69-72.
73. Martling CR: Sensory nerves containing tachykinins and CGRP in the lower airways: functional implications for bronchoconstriction, vasodilation, and protein extravasation. Acta Physiol Scand 1987, 563:S1-S57.
74. Uddman R, Luts A, Sundler F: Occurrence and distribution of calcitonin gene related peptide in mammalian respiratory tract and middle ear. Cell Tissue Res 1985, 214:551-555.
75. Mak JCW, Barnes PJ: Autoradiographic localization of calcitonin gene-related peptide binding sites in human and guinea pig lung. Peptides 1988, 9:957-964.
76. Palmer JB, Cuss FM, Mulderry PK, Ghatei MA, Springall DR, Cadieux A, Bloom SR, Polak JM, Barnes PJ: Calcitonin gene-related peptide is localised to human airway nerves and potentially constricts human airway smooth muscle. Br J Pharmacol 1987, 91:95-101.
77. Latinen LA, Heino M, Kava T, Haahtela T: Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis 1985, 131:599-606.
78. Bowden J, Gibbins IL: Relative density of substance P-immunoreactive nerve fibers in tracheal epithelium of a range of species. FASEB J 1992, 6:A1276.
79. Tomaki M, Ichinose M, Miura M, Hirayama Y, Yamaguchi H, Nakajima N, Shirato K: Elevated substance P content in induced sputum from patients with asthma and patients with bronchitis. Am J Respir Crit Care Med 1995, 151:613-617.
80. Nieber K, Baumgarten CR, Rathsack R, Furkert J, Oehme P, Kunkel G: Substance P and beta-endorphin-like immunoreactivity in lavage fluid of subjects with and without allergic asthma. J Allergy Clin Immunol 1992, 90:646-652.
81. Ollerenshaw SL, Jarvis D, Sullivan CE, Woolcock AJ: Substance P-immunoreactive nerves in airways from asthmatics and nonasthmatics. Eur Respir J 1994, 4:673-682.
82. Lilly CM, Bai TR, Shore SA, Hall AE, Drazen JM: Neuropeptide content of lungs from asthmatics and nonasthmatics. Am J Respir Crit Care Med 1995, 151:548-553.
83. Baraniuk JN, Mak J, Letarte M, Davis R, Twort C, Barnes PJ: Neutral endopeptidase mRNA expression in airways. Am Rev Respir Dis 1992, 145:A40.
84. Cheung D, Timmers MC, Zwinderman AH, den Hartigh J, Dijkman JH, Sterk PJ: Neutral endopeptidase activity and airway hyperresponsiveness to neurokinin A in asthmatic sujects in vivo. Am Rev Respir Dis 1993, 148:1467-1473.
85. Cheung D, Bell EH, den Hartigh J, Djkman JH, Sterk PJ: The effect of inhaled neutral endopeptidase inhibitor, thiorphan, on airway responses to neurokinin A in normal humans in vivo. Am Rev Respir Dis 1992, 145:1275-1280.
86. Nichol GM, O'Connor BH, Le Compte JM, Chung KF, Barnes PJ: Effect of neutral endopeptidase inhibitor on airway function and bronchial responsiveness in asthmatic subjects. Eur J Clin Pharmacol 1992, 42:495-498.
87. Diamant Z, Van Der Veen H, Kuijpers EA, Bakker PF, Sterk PJ: The effect of inhaled thiorphan on allergen-induced airway responses in asthmatic patients. Clin Exp Allergy 1991, 26:525-532.
88. Cunha FQ, Poole S, Lorenzetti BB, Ferreira SH: The pivotal role of tumor necrosis factor-alpha in the development of inflammatory hyperalgesia. Br J Pharmacol 1992, 107:660-664.
89. Hulsmann AR, Raatgeep HR, Saxena PR, Kerrebijn KF, de Jongste JC: Bradykinin-induced contraction of human peripheral airways mediated by both bradykinin and beta-2 and thromboxane prostanoid receptors. Am J Respir Crit Care Med 1994, 150:1012-1018.
90. Fuller RW, Dixon CMS, Cuss FMC, Barnes PJ: Bradykinin-induced bronchoconstriction in man: mode of action. Am Rev Respir Dis 1987, 135:176-180.
91. Barnes PJ: Neural control of human airways in health and diseases. Am Rev Respir Dis 1986, 134:1289-1314.
92. Lalloo UG, Barnes PJ: Pathophysiology and clinical presentations of cough. J Allergy Clin Immunol 1996, 98:S91-S97. A review of the role of neuropeptides in the cough in asthma patients.
93. Ujiie Y, Sekizawa K, Aikawa T, Sasaki H: Evidence for substance P as an endogenous substance causing cough in guinea pigs. Am Rev Respir Dis 1993, 148:1628-1632.
94. Ryan WJ: Processing of endogenous polypeptides by the lung. Annu Rev Physiol 1980, 44:241-255.
95. Ichinose M, Nakajima N, Takahashi T, Yamauchi H, Inoue H, Takishima T: Protection against bradykinin-induced bronchoconstriction in asthmatic patients by neurokinin antagonist Lancet 1992, 340:1248-1251.
96. Elwood WE, Lötvall JO, Parnes PJ, Chung KF: Loop diuretics inhibit cholinergic and noncholinergic nerves in guinea pig airways in vitro. Am Rev Respir Dis 1991, 143:1340-1343.
97. Verleden GM, Belvisi MG, Stretton CD, Parnes PJ: Nedocromil sodium modulates nonadrenergic, noncholinergic bronchoconstrictor nerves in vitro. Am Rev Respir Dis 1991, 143:114-118.
98. Dixon CMS, Fuller RW, Barnes PJ: The effect of nedocromil sodium on sulfur oxide-induced bronchoconstriction. Thorax 1987, 42:462-465.
99. Barnes PJ: Effect of inhaled furosemide on metabisulfite- and methacholine-induced bronchoconstriction and nasal potential difference in asthmatic subjects. Am Rev Respir Dis 1990, 142:576-580.
100. McAlpine LG, Thompson NC: Lidocaine-induced bronchoconstriction in asthmatic patients: relation to histamine airway responsiveness and effect of preservative. Chest 1989, 96:1012-1015.
101. Verleden GM, Belvisi MG, Rabe KF, Barnes PJ: Inhibition of nondrenergic, noncholinergic bronchoconstriction in guinea pig airways in vitro by beta2-adrenoreceptors. J Appl Physiol 1993, 74:1195-1199.
102. Belvisi MG, Chung KF, Barnes PJ: Opioid modulation of noncholinergic neural bronchoconstriction in guinea pig in vitro. Br J Pharmacol 1988, 95:413-418.
103. Ichinose M, Belvisi MG, Barnes PJ: Histamine H3-receptors inhibit neurogenic microvascular leakage in airways. J Appl Physiol 1990, 68:21-25.
104. O'Connor BJ, Lecomte JM, Barnes PJ: Effect of inhaled H3-receptor antagonist on airway responses to sodium metabisulfite in asthma. Br J Clin Pharmacol 1993, 35:55-57.